Our results partially confirmed those presented by Oku et al. [15], since they incubated PBMCs or HUVEC directly with aPS/PT isolated from APS patients or a murine monoclonal aPS/PT antibody, without any pre-treatment with LPS. This evidence concerns the gene F2 and autoimmune polyendocrinopathy.